Hemoglobin A1c Monitoring - Global Strategic Business Report

News provided by

Apr 24, 2014, 01:10 ET

DUBLIN, April 24, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/jwng9z/hemoglobin_a1c) has announced the addition of the "Hemoglobin A1c Monitoring - Global Strategic Business Report" report to their offering.

Research and Markets Logo. (PRNewsFoto/PR NEWSWIRE EUROPE)

(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

This report analyzes the worldwide markets for Hemoglobin A1c Monitoring in US$ Million by the following Test Types: HbA1c Laboratory Testing, and HbA1c Point of Care Testing.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2012 through 2020. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 27 companies including many key and niche players such as -

Abbott Laboratories
ARKRAY, Inc.
Axis-Shield plc
Bayer Healthcare Diabetes Care
Beckman Coulter, Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
2. DIABETES A BRIEF PROFILE OF THE DISEASE
3. PRODUCT OVERVIEW
4. PRODUCT APPROVALS/INTRODUCTIONS
5. RECENT INDUSTRY ACTIVITY
6. FOCUS ON SELECT PLAYERS
7. GLOBAL MARKET PERSPECTIVE

III. MARKET
1. THE UNITED STATES
2. CANADA
3. JAPAN
4. EUROPE
5. ASIA-PACIFIC
6. LATIN AMERICA
7. REST OF WORLD

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 27 (including Divisions/Subsidiaries 35)